General Information of the Compound
Compound ID
CP0559209
Compound Name
5-[2-(3-naphthalen-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pentan-1-ol
    Show/Hide
Structure
Formula
C22H27N3O2
Molecular Weight
365.477
Canonical SMILES
OCCCCCN1CCCCC1c1nc(no1)-c1ccc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C22H27N3O2/c26-15-7-1-5-13-25-14-6-4-10-20(25)22-23-21(24-27-22)19-12-11-17-8-2-3-9-18(17)16-19/h2-3,8-9,11-12,16,20,26H,1,4-7,10,13-15H2
    Show/Hide
InChIKey
VGZLEPWHYSCXKG-UHFFFAOYSA-N
Physicochemical Property
logP
4.5794
Rotatable Bonds
7
Heavy Atom Count
27
Polar Areas
62.39
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 155551587
ChEMBL ID
CHEMBL4541043
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 10500 nM
   TI
   LI
   LO
   TS